An alternative explanation, alongside the 'ceiling effect,' is that these non-specific, systemic markers (NLR, CRP) are simply not sensitive enough to detect the specific, low-grade inflammation associated with T2DM pathogenesis once high-grade obesity-driven inflammation is already present. The gene discussed is CRP; the disease is Obesity.